Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuo Fujihara

Showing results (1-10 of 292) with videos related to

Pageof 30
Sort By:
Journal of the Neurological Sciences|March 15, 2011
Neuromyelitis optica and astrocytic damage in its pathogenesisKazuo Fujihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 11, 2008
[Update on the etiology and pathogenesis of multiple sclerosis and neuromyelitis optica]Kazuo Fujihara
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2019
MOG-antibody-associated disease is different from MS and NMOSD and should be classified as a distinct disease entity - CommentaryKazuo Fujihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2003
[Clinical subtypes of multiple sclerosis and the immuno-pathogeneses]Kazuo Fujihara
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 12, 2012
[Treatment of neuromyelitis optica]Kazuo Fujihara
Rinsho Shinkeigaku = Clinical Neurology|January 24, 2008
[Neuromyelitis optica: the disease entity, pathogenesis and therapy]Kazuo Fujihara
Current Opinion in Neurology|March 21, 2019
Neuromyelitis optica spectrum disorders: still evolving and broadeningKazuo Fujihara
Rinsho Shinkeigaku = Clinical Neurology|April 17, 2007
[Laboratory findings in optic-spinal multiple sclerosis]Kazuo Fujihara
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 16, 2013
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)]Kazuo Fujihara
Brain Pathology (Zurich, Switzerland)|October 15, 2013
New insights, promises and challengesKazuo Fujihara, Claudia Lucchinetti
Pageof 30

Showing results (1-10 of 292) with videos related to

Sort By:
Pageof 30
Journal of the Neurological Sciences|March 15, 2011
Neuromyelitis optica and astrocytic damage in its pathogenesisKazuo Fujihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 11, 2008
[Update on the etiology and pathogenesis of multiple sclerosis and neuromyelitis optica]Kazuo Fujihara
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2019
MOG-antibody-associated disease is different from MS and NMOSD and should be classified as a distinct disease entity - CommentaryKazuo Fujihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2003
[Clinical subtypes of multiple sclerosis and the immuno-pathogeneses]Kazuo Fujihara
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 12, 2012
[Treatment of neuromyelitis optica]Kazuo Fujihara
Rinsho Shinkeigaku = Clinical Neurology|January 24, 2008
[Neuromyelitis optica: the disease entity, pathogenesis and therapy]Kazuo Fujihara
Current Opinion in Neurology|March 21, 2019
Neuromyelitis optica spectrum disorders: still evolving and broadeningKazuo Fujihara
Rinsho Shinkeigaku = Clinical Neurology|April 17, 2007
[Laboratory findings in optic-spinal multiple sclerosis]Kazuo Fujihara
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 16, 2013
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)]Kazuo Fujihara
Brain Pathology (Zurich, Switzerland)|October 15, 2013
New insights, promises and challengesKazuo Fujihara, Claudia Lucchinetti
Pageof 30